Last Updated: 31-07-2025 | Format: PDF | Report ID:20483
| Metrics | Details |
|---|---|
| Years | 2020-2035 |
| Base Year | 2025 |
| Market Size | 205000 |
| Regions | United States, Canada, Mexico |
| Segments | Oral Drug Delivery, Pulmonary Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery, Nasal Drug Delivery, Topical Drug Delivery, Cancer, Diabetes, Cardiovascular Diseases, Infectious Diseases, Respiratory Diseases, Others |
| Players | Johnson & Johnson, Pfizer Inc., Merck & Co., Inc., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, AbbVie Inc., Amgen Inc., AstraZeneca PLC, Sanofi, GlaxoSmithKline plc, Bristol-Myers Squibb, Eli Lilly and Company, Gilead Sciences, Inc., Becton, Dickinson and Company |